If You Invested in BlueRiver Acquisition Corp. (BLUA)
Looking for the current price? See the BLUA quote & overviewWhat $1,000 or $10,000 in BLUA Would Be Worth Today
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Mar 22, 2021 |
|---|---|---|---|---|
| $1,000 | — | $1,093 +9% | — | $1,093 +9% |
| $10,000 | — | $10,927 +9% | — | $10,927 +9% |
Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for BLUA$1,000 Investment Over Time
BLUA vs S&P 500Year-by-Year Returns
BLUA annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2021 | $9.71 | $9.72 | +0.1% | +0.1% |
| 2022 | $9.73 | $10.09 | +3.7% | +3.9% |
| 2023 | $10.08 | $10.66 | +5.8% | +9.8% |
| 2024 | $10.66 | $10.61 | -0.5% | +9.3% |
About BlueRiver Acquisition Corp.
Surgical & Medical Instruments & Apparatus · NYSE
BlueRiver Acquisition Corp. (BLUA) is a special purpose acquisition company (SPAC) domiciled in the Cayman Islands. According to company disclosures, it was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Its securities have traded under the ticker symbol BLUA.
BlueRiver Acquisition Corp. has focused on identifying a suitable business combination target rather than operating an ongoing commercial business of its own. As described in its public communications, the company’s structure allows it to pursue a merger or similar transaction, after which the combined entity may operate under a different name and business profile. Until such a transaction is completed, BlueRiver’s activities are largely limited to evaluating potential targets and managing the capital raised in its initial public offering.
Corporate structure and jurisdiction
The company is organized as a Cayman Islands exempted company. In its SEC filings, BlueRiver Acquisition Corp. refers to itself as a special purpose acquisition company, with ordinary shares that were initially sold to public investors in an initial public offering. The company’s governing documents, including its amended and restated memorandum and articles of association, set out deadlines by which it must complete a business combination or move toward winding up and redeeming public shares.
Listing history and trading venues
BlueRiver’s securities have been listed on multiple U.S. trading venues. The company has disclosed that its units, Class A ordinary shares and redeemable warrants were initially listed on the New York Stock Exchange and later transferred to NYSE American LLC. In one Business Wire announcement, BlueRiver stated that it intended to transfer its listing from the New York Stock Exchange to NYSE American and that it received written confirmation that it had been cleared to file an initial listing application with NYSE American. A subsequent release noted that BlueRiver received final approval for listing from NYSE American.
NYSE American later announced that its regulatory staff determined to commence proceedings to delist BlueRiver’s securities because the company did not consummate a business combination within the time period specified in its initial public offering registration statement. Following an appeal and the company’s later withdrawal of that appeal, NYSE American stated that it would suspend trading in BlueRiver’s Class A ordinary shares and units and apply to the Securities and Exchange Commission to delist the securities. An SEC Form 8-K filing identifies the Class A ordinary shares, units and redeemable warrants as trading on the OTC Expert Market, with BLUA, BLUA.U and BLUA.WS as the respective symbols.
Business combination efforts
BlueRiver Acquisition Corp. has described its purpose as effecting a business combination with one or more businesses. In a Business Wire communication, the company reported entering into an Agreement and Plan of Merger with Spinal Stabilization Technologies, LLC (SST) and a merger subsidiary. That communication explains that SST is a medical device company and that, upon closing of the proposed transaction, the combined company would operate as Spinal Stabilization Technologies and be listed on an approved stock exchange. BlueRiver also disclosed that it filed a registration statement with the SEC that includes a proxy statement related to the proposed transaction, and that additional documents related to the merger agreement would be filed with the SEC.
In a later press release, BlueRiver stated that it received a notice from NYSE American regarding the commencement of delisting proceedings because it had not completed a business combination within the required timeframe. In the same communication, the company noted that it agreed with SST to extend the date on which the merger agreement could be terminated if the closing had not occurred, moving the outside date from early February to the end of March of that year. These disclosures indicate that BlueRiver has pursued, but not yet completed, a business combination within the original timeframe set out in its charter and listing rules.
Charter provisions and extension votes
BlueRiver’s SEC filings describe how its charter governs the timeline for completing a business combination. A definitive proxy statement explains that the company’s existing charter provided a deadline by which it must complete an initial business combination, after which it would be required to cease operations except for winding up, redeem the public shares and, subject to applicable law, liquidate and dissolve. The same proxy statement presents an extension proposal to amend the charter so that the board of directors could, without another shareholder vote, extend the deadline by several three-month periods, up to a total of 66 months from the closing of the initial public offering.
An 8-K filing reports on an extraordinary general meeting at which shareholders voted on the extension proposal and an adjournment proposal. According to that filing, shareholders approved the extension proposal, allowing the board to elect to extend the date by which the company must complete a business combination, subject to the conditions described in the amended charter. The filing also notes that the adjournment proposal was not presented because there were sufficient votes to approve the extension proposal.
Capital held in trust
The proxy materials describe how proceeds from BlueRiver’s initial public offering were placed in a trust account. The company states that, upon closing of the offering, a specified amount was deposited in a U.S. trust account with a trustee and initially invested in U.S. government securities. The proxy statement discusses regulatory considerations under the Investment Company Act of 1940 for SPACs that hold trust assets in securities beyond a certain period. It further explains that BlueRiver converted the trust assets into cash in a non-interest bearing account and later deposited them in an interest-bearing demand deposit account at a bank, with interest accruing at a variable rate. These details illustrate how the company has managed its trust account while working toward a potential business combination.
Status as a SPAC and investor considerations
As a SPAC, BlueRiver Acquisition Corp. does not describe any operating business of its own in the provided materials. Instead, its disclosures focus on its structure, trust account, deadlines for completing a business combination and the regulatory framework under which it operates. Investors considering BLUA historically would have evaluated the company’s ability to identify and complete a suitable business combination within the time allowed by its charter and exchange rules, as well as the terms of any proposed transaction disclosed in SEC filings and proxy statements.
Because NYSE American has initiated delisting proceedings and suspended trading in BlueRiver’s securities, and because the company has sought extensions to its business combination deadline, the trading status and future of BLUA depend on regulatory actions, shareholder approvals and the outcome of any proposed business combination. The SEC filings and proxy materials provide detailed information on these processes, including shareholder voting results, charter amendments and the handling of public share redemptions in the event of a winding up.
Frequently Asked Questions
BlueRiver Acquisition Corp. investment returns
How much would $1,000 invested in BlueRiver Acquisition Corp. be worth today?
If you invested $1,000 in BlueRiver Acquisition Corp. (BLUA) 5 years ago on 2021-07-12, your investment would be worth $1,093 today, representing a +9.3% total return, growing at a compounded rate of 2.9% per year (CAGR).
Has BlueRiver Acquisition Corp. outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare BLUA performance over available time periods.
What is BlueRiver Acquisition Corp.'s average annual return?
The compound annual growth rate (CAGR) of BLUA over the past 5 years is 2.9%, growing at a compounded rate each year. Individual years vary significantly — BLUA's best recent year was 2023 (+5.8%) and worst was 2024 (-0.5%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.